These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10445022)

  • 21. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
    Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
    J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome stability, DNA recombination and the BRCA2 tumour suppressor.
    Venkitaraman AR
    Curr Opin Cell Biol; 2001 Jun; 13(3):338-43. PubMed ID: 11343905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase.
    Chow JP; Siu WY; Fung TK; Chan WM; Lau A; Arooz T; Ng CP; Yamashita K; Poon RY
    Mol Biol Cell; 2003 Oct; 14(10):3989-4002. PubMed ID: 14517313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
    Crook T; Brooks LA; Crossland S; Osin P; Barker KT; Waller J; Philp E; Smith PD; Yulug I; Peto J; Parker G; Allday MJ; Crompton MR; Gusterson BA
    Oncogene; 1998 Oct; 17(13):1681-9. PubMed ID: 9796697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
    Chen J; Silver DP; Walpita D; Cantor SB; Gazdar AF; Tomlinson G; Couch FJ; Weber BL; Ashley T; Livingston DM; Scully R
    Mol Cell; 1998 Sep; 2(3):317-28. PubMed ID: 9774970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The BRCA2 gene product functionally interacts with p53 and RAD51.
    Marmorstein LY; Ouchi T; Aaronson SA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13869-74. PubMed ID: 9811893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDAC2/3 binding and deacetylation of BubR1 initiates spindle assembly checkpoint silencing.
    Park I; Kwon MS; Paik S; Kim H; Lee HO; Choi E; Lee H
    FEBS J; 2017 Dec; 284(23):4035-4050. PubMed ID: 28985013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax.
    Sasaki M; Sugimoto K; Tamayose K; Ando M; Tanaka Y; Oshimi K
    Oncogene; 2006 Jun; 25(26):3621-7. PubMed ID: 16449967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1.
    Grigorova M; Staines JM; Ozdag H; Caldas C; Edwards PA
    Cytogenet Genome Res; 2004; 104(1-4):333-40. PubMed ID: 15162061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage.
    Minn AJ; Boise LH; Thompson CB
    Genes Dev; 1996 Oct; 10(20):2621-31. PubMed ID: 8895663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.
    Smith PD; Crossland S; Parker G; Osin P; Brooks L; Waller J; Philp E; Crompton MR; Gusterson BA; Allday MJ; Crook T
    Oncogene; 1999 Apr; 18(15):2451-9. PubMed ID: 10229196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of BRCA2 gene in sporadic breast tumours.
    Bièche I; Noguès C; Lidereau R
    Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage.
    Taylor SS; McKeon F
    Cell; 1997 May; 89(5):727-35. PubMed ID: 9182760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gain of function properties of mutant p53 proteins at the mitotic spindle cell cycle checkpoint.
    Hixon ML; Flores A; Wagner M; Gualberto A
    Histol Histopathol; 2000 Apr; 15(2):551-6. PubMed ID: 10809376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.
    Yoon DS; Wersto RP; Zhou W; Chrest FJ; Garrett ES; Kwon TK; Gabrielson E
    Am J Pathol; 2002 Aug; 161(2):391-7. PubMed ID: 12163363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function.
    Iida S; Hirota T; Morisaki T; Marumoto T; Hara T; Kuninaka S; Honda S; Kosai K; Kawasuji M; Pallas DC; Saya H
    Oncogene; 2004 Jul; 23(31):5266-74. PubMed ID: 15122335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.
    Bennett LM; McAllister KA; Ward T; Malphurs J; Collins NK; Seely JC; Davis BJ; Wiseman RW
    Toxicol Pathol; 2001; 29(1):117-25. PubMed ID: 11215675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.